Mind over matter? Neurological sensor technology and prosthetics

Cara Livernois | | Health Exec | Economics

Prosthetics are primed for a revolution with the continuing advancement of technology. With improved movement, structure and range, today's prosthetics are miles ahead of what they were in the past. They have evolved into being a part of the human body rather than an awkward piece of equipment.

One of the people at the front lines of prosthetics evolution is Michael McLoughlin, program manager and chief engineer for the Johns Hopkins University’s Applied Physics Laboratory, who has lead the development of “modular prosthetic limb” technologies responsible for the most life-like prosthetics on the market today.

In an interview with STAT, McLoughlin spoke about his work on making most advanced prosthetics in the nation.

Click the link below for the full interview:

Next-generation prosthetics aim to rewire the brain and the body Twitter Facebo…

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Bipartisan group of 233 House members call for Medicare reform
Wartime powers enacted to address nationwide IV fluid shortage
Cardiologist compensation still rising, especially in invasive and interventional cardiology
Baxter begins importing IV supplies as 86% of providers report shortages
CMS proposes rule to combat gray market health insurance scams
Private equity firm buys controlling stake in Surescripts

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup